Human plasminogen-derived N-acetyl-Arg-Leu-Tyr-Glu antagonizes VEGFR-2 to prevent blood-retinal barrier breakdown in diabetic mice.

MLA

Park, Wonjin, et al. “Human Plasminogen-Derived N-Acetyl-Arg-Leu-Tyr-Glu Antagonizes VEGFR-2 to Prevent Blood-Retinal Barrier Breakdown in Diabetic Mice.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 134, Feb. 2021, p. 111110. EBSCOhost, https://doi.org/10.1016/j.biopha.2020.111110.

APA

Park, W., Kim, J., Choi, S., Kim, T., Park, M., Kim, S., You, J.-C., Kim, J. H., Ha, K.-S., Lee, J.-H., Kwon, Y.-G., & Kim, Y.-M. (2021). Human plasminogen-derived N-acetyl-Arg-Leu-Tyr-Glu antagonizes VEGFR-2 to prevent blood-retinal barrier breakdown in diabetic mice. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 134, 111110. https://doi.org/10.1016/j.biopha.2020.111110

Chicago

Park, Wonjin, Joohwan Kim, Seunghwan Choi, Taesam Kim, Minsik Park, Suji Kim, Ji-Chang You, et al. 2021. “Human Plasminogen-Derived N-Acetyl-Arg-Leu-Tyr-Glu Antagonizes VEGFR-2 to Prevent Blood-Retinal Barrier Breakdown in Diabetic Mice.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 134 (February): 111110. doi:10.1016/j.biopha.2020.111110.